COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
Study Information
Study Attribute Value
CEBS Accession Number: 002-02914-0001-0000-9
Chemical Name: Tolazamide
CASRN: 1156-19-0
NTP Study Type: Genetic Toxicology - Mammalian Cell Cytogenetics
NTP Study ID: 225955_SCE
Study Result: Negative

Study Result: Negative
Activation Trial Trial Call
No Activation  Negative 
Induced Rat Liver S9  1_S9  Negative 

Trial #: 1    Activation: No Activation    Date: 10/08/1985    Trial Call: Negative   
  Dose
µg/mL
Number
Cells
Examined
Number
Chromosomes
Examined
Total
Number
SCEs
SCE /
Chromosome
SCE /
Cell
Hours in
BRDU
% Increase
Over Solvent
Control
Vehicle Control Dimethyl Sulfoxide
0         
50 1049 472 0.450 9.44 27.5 0.000
Test Chemical Tolazamide
16         
50 1050 512 0.488 10.24 27.5 8.371
50         
50 1052 515 0.490 10.30 27.5 8.799
160         
50 1050 516 0.491 10.32 27.5 9.218
500         
50 1048 558 0.532 11.16 27.5 18.333
1600         
0 0 0 0.000 0.00 32.0 N/A
Positive Control Mitomycin-C
 0.0E-4    
50 1048 620 0.592 12.40 27.5 31.481
Mitomycin-C
 0.005     
10 210 260 1.238 26.00 27.5 175.161
Trend: 2.467        
Probability: 0.007        

Trial #: 1_S9    Activation: Induced Rat Liver S9    Date: 10/08/1985    Trial Call: Negative   
  Dose
µg/mL
Number
Cells
Examined
Number
Chromosomes
Examined
Total
Number
SCEs
SCE /
Chromosome
SCE /
Cell
Hours in
BRDU
% Increase
Over Solvent
Control
Vehicle Control Dimethyl Sulfoxide
0         
50 1048 478 0.456 9.56 26.0 0.000
Test Chemical Tolazamide
160         
50 1048 473 0.451 9.46 26.0 -1.046
500         
50 1050 454 0.432 9.08 26.0 -5.202
1600         
50 1048 511 0.488 10.22 26.0 6.904
2500         
50 1047 473 0.452 9.46 26.0 -0.952
Positive Control Cyclophosphamide
 0.15      
50 1049 739 0.704 14.78 26.0 54.455
Cyclophosphamide
 0.6       
10 209 314 1.502 31.40 26.0 229.395
Trend: 0.546        
Probability: 0.293